| Filed On | Filing |
|---|---|
| 03 Nov 2026 |
Form 4: Malzahn Craig, Chief Technology Officer
Received 27,777 shares as a grant or award |
| 03 Nov 2026 |
Form 4: Christmas Patrick J., Chief Strategy & Legal Officer
Received 34,722 shares as a grant or award |
| 03 Nov 2026 |
Form 4: Pakola Steve, Chief Medical Officer
Received 34,722 shares as a grant or award |
| 03 Nov 2026 |
Form 4: Chan Mitchell, Chief Financial Officer
Received 24,305 shares as a grant or award |
| 03 Sep 2026 |
Form 4: Malzahn Craig, Chief Technology Officer
Gave up 234 shares to cover exercise price or tax ($2.18K) |
| 03 Sep 2026 |
Form 4: Chan Mitchell, Chief Financial Officer
Gave up 4,902 shares to cover exercise price or tax ($45.7K) |
| 27 Aug 2026 |
Form 4: Ciongoli Gregory Austin, Director
Received 15,432 shares as a grant or award · Granted 69,609 Stock Options (Right to buy) · Bought 49,196 shares ($450K) · 1 more |
| 04 Aug 2026 |
Form 4: Pakola Steve, Chief Medical Officer
Gave up 7,468 shares to cover exercise price or tax ($72.4K) |
| 04 Aug 2026 |
Form 4: Christmas Patrick J., Chief Strategy & Legal Officer
Gave up 4,699 shares to cover exercise price or tax ($45.5K) |
| 06 Jul 2026 |
Form 4: Simpson Curran, Director
Received 951 shares as a grant or award ($6.65K) · Received 1,453 shares as a grant or award ($14.8K) · Gave up 6,818 shares to cover exercise price or tax ($89.2K) |
| 06 Jul 2026 |
Form 4: Pakola Steve, Chief Medical Officer
Received 2,161 shares by exercise or conversion ($17K) · Sold 2,161 shares ($29.5K) |
| 01 Jul 2026 |
Form 4: Pakola Steve, Chief Medical Officer
Sold 19,608 shares ($216K) · Received 36,725 shares by exercise or conversion ($289K) · Sold 36,725 shares ($472K) |
| 02 Jun 2026 |
Form 4: Tasse Daniel, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Stump David C, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Zachary Jennifer, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Mills Kenneth T., Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Migausky George V, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Karabelas Argeris N, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Glucksmann Alexandra, Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
| 02 Jun 2026 |
Form 4: Fox Allan M., Director
Received 9,807 shares as a grant or award · Granted 46,600 Stock Options (Right to Buy) |
Loading...